Characteristic | Total Sample N = 54 | A: Min activity/rare Integration N = 20 | B: Min activity/limited integration N = 4 | C: Mod activity/moderate integration N = 16 | D: Mod activity/full integration N = 10 | E: High activity/full integration N = 4 |
---|---|---|---|---|---|---|
Age | 66.3 ± 8.8 | 69.0 ± 7.8 | 63.3 ± 8.1 | 65.4 ± 10.1 | 65.6 ± 8.6 | 61.3 ± 10.4 |
Sex, n (%) | Â | Â | Â | Â | Â | Â |
 Male | 31 (57) | 10 (50) | 1 (25) | 10 (63) | 7 (70) | 3 (25) |
 Female | 23 (43) | 10 (50) | 3 (75) | 6 (11) | 3 (30) | 1 (25) |
Ethnicity, n (%) | Â | Â | Â | Â | Â | Â |
 Non-Hispanic/Non-Latino | 54 (100) | 20 (100) | 4 (100) | 16 (100) | 10 (100) | 4 (100) |
Race, n (%) | Â | Â | Â | Â | Â | Â |
 White | 32 (59) | 12 (60) | 4 (100) | 6 (38) | 7 (70) | 3 (75) |
 African-American | 21 (39) | 8 (40) | – | 9 (56) | 3 (30) | 1 (25) |
 Asian | 1 (2) | – | – | 1 (6) | – |  |
Stroke type, n (%) | Â | Â | Â | Â | Â | Â |
 Ischemic | 48 (89) | 20 (100) | 4 (100) | 11(69) | 9 (90) | 4 (100) |
 Hemorrhagic | 6 (11) | – | – | 5 (31) | 1 (10) | – |
Concordance, n (%) | 23 (43) | 8 (40) | 1 (25) | 4 (25) | 7 (70) | 3 (75) |
Time post stroke in days* | 13 (12,15) | 13 (12,14) | 14 (13,15) | 13 (12,14) | 15 (13,16) | 16 (13, 18) |
Week post stroke of UL performance category, n (%) | Â | Â | Â | Â | Â | Â |
 Week 6 | 2 (4) | 1 (5) | – | – | 1 (10) | – |
 Week 8 | 4 (7) | 3 (15) | – | 1 (6) | – | – |
 Week 12 | 5 (9) | 3 (15) | – | 2 (13) | – | – |
 Week 16 | 4 (7) | 2 (10) | – | 1 (6) | 1 (10) | – |
 Week 20 | 3 (6) | 2 (10) | – | 1 (6) | – | – |
 Week 24 | 36 (67) | 9 (45) | 4 (100) | 11 (69) | 8 (80) | 4 (100) |
Living status pre-stroke n (%) | Â | Â | Â | Â | Â | Â |
 Alone, independent | 11 (20) | 5 (25) | 1 (25) | 5 (31) | – | – |
 Others, independent | 43 (80) | 15 (75) | 3 (75) | 11 (69) | 10 (100) | 4 (100) |
Living status 2-weeks post stroke, n (%) | Â | Â | Â | Â | Â | Â |
 Inpatient | 47 (87) | 20 (100) | 3 (75) | 14 (87) | 7 (70) | 3 (75) |
 Home | 7 (13) | – | 1 (25) | 2 (13) | 3 (30) | 1 (25) |
ADI | 75 (39, 86) | 80 (41, 88) | 66 (48, 78) | 76 (45, 87) | 67 (31, 84) | 31 (21, 47) |
Upper limb measures | ||||||
 ARAT | 20 (0, 43) | 0 (0, 3.3) | 4 (0, 20) | 37 (23, 48) | 45 (30, 53) | 37 (28, 41) |
 SAFE | 7 (1, 8) | 1 (1, 4) | 5 (1, 8) | 8 (7, 8) | 8 (8, 8) | 8 (7, 8) |
 UEFM | 37 (10, 57) | 10 (8, 21.3) | 23 (9, 43) | 54 (36, 56) | 59 (48, 61) | 54 (43, 57) |
Non-motor clinical measures | ||||||
 CES-D | 14.0 ± 9.5 | 18.2 ± 10.3 | 14.0 ± 9.1 | 15.5 ± 8.2 | 7.0 ± 6.1 | 4.8 ± 1.7 |
 Mesulam | 0 (0, 3) | 1 (0, 7) | 1 (0, 4) | 1 (0, 4) | 0 (0, 1) | -1 (-1, 1) |
 MOCA | 17.6 ± 7.1 | 14.6 ± 7.9 | 20.3 ± 8.3 | 18.3 ± 7.1 | 20.5 ± 4.1 | 20.3 ± 4.4 |
 NIHSS | 6 (4, 10) | 10 (6, 15) | 5 (4, 9) | 5 (3, 8) | 4 (4, 6) | 3 (3, 4) |